Properties
                                        
                            Description
                            Tirabrutinib is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells.
                         
                                                                            
                                                            
                            Molecular Formula
                            C25H22N6O3
                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                            
                                                                                                                                                                                            
                            Identity
                            Confirmed by NMR/HPLC/MS.
                         
                                                                                                                                                            
                            Applications
                            Tirabrutinib is used to research its effects on B-cell malignancies through the inhibition of BTK signaling pathways.